McClung MR - Search Results

1

The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.

Tankó LB, McClung MR, Schimmer RC, Mahoney P, Christiansen C. Tankó LB, et al. Among authors: mcclung mr. Bone. 2003 Apr;32(4):421-6. doi: 10.1016/s8756-3282(03)00033-4. Bone. 2003. PMID: 12689686 Clinical Trial.

2

Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC Study.

Ravn P, Overgaard K, Huang C, Ross PD, Green D, McClung M. Ravn P, et al. Osteoporos Int. 1996;6(4):308-13. doi: 10.1007/BF01623390. Osteoporos Int. 1996. PMID: 8883120 Clinical Trial.

3

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ. Hosking D, et al. N Engl J Med. 1998 Feb 19;338(8):485-92. doi: 10.1056/NEJM199802193380801. N Engl J Med. 1998. PMID: 9443925 Free article. Clinical Trial.

4

Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.

Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C. Ravn P, et al. J Clin Endocrinol Metab. 1999 Jul;84(7):2363-8. doi: 10.1210/jcem.84.7.5847. J Clin Endocrinol Metab. 1999. PMID: 10404804 Clinical Trial.

5

Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C. Ravn P, et al. J Bone Miner Res. 1999 Sep;14(9):1622-7. doi: 10.1359/jbmr.1999.14.9.1622. J Bone Miner Res. 1999. PMID: 10469292 Free article. Clinical Trial.

6

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial.

Ravn P, Bidstrup M, Wasnich RD, Davis JW, McClung MR, Balske A, Coupland C, Sahota O, Kaur A, Daley M, Cizza G. Ravn P, et al. Among authors: mcclung mr. Ann Intern Med. 1999 Dec 21;131(12):935-42. doi: 10.7326/0003-4819-131-12-199912210-00005. Ann Intern Med. 1999. PMID: 10610644 Clinical Trial.

7

Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group.

Ravn P, Weiss SR, Rodriguez-Portales JA, McClung MR, Wasnich RD, Gilchrist NL, Sambrook P, Fogelman I, Krupa D, Yates AJ, Daifotis A, Fuleihan GE. Ravn P, et al. Among authors: mcclung mr. J Clin Endocrinol Metab. 2000 Apr;85(4):1492-7. doi: 10.1210/jcem.85.4.6549. J Clin Endocrinol Metab. 2000. PMID: 10770187 Clinical Trial.

8

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.

McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH 3rd, Ensrud KE, Burdeska A, Mills T; Oral Ibandronate Study Group. McClung MR, et al. J Bone Miner Res. 2004 Jan;19(1):11-8. doi: 10.1359/JBMR.0301202. J Bone Miner Res. 2004. PMID: 14753731 Free article. Clinical Trial.

9

Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study.

McClung MR, Wasnich RD, Hosking DJ, Christiansen C, Ravn P, Wu M, Mantz AM, Yates J, Ross PD, Santora AC 2nd; Early Postmenopausal Intervention Cohort Study. McClung MR, et al. J Clin Endocrinol Metab. 2004 Oct;89(10):4879-85. doi: 10.1210/jc.2003-031672. J Clin Endocrinol Metab. 2004. PMID: 15472179 Clinical Trial.

10

Changes in bone density and turnover after alendronate or estrogen withdrawal.

Wasnich RD, Bagger YZ, Hosking DJ, McClung MR, Wu M, Mantz AM, Yates JJ, Ross PD, Alexandersen P, Ravn P, Christiansen C, Santora AC 2nd; Early Postmenopausal Intervention Cohort Study Group. Wasnich RD, et al. Among authors: mcclung mr. Menopause. 2004 Nov-Dec;11(6 Pt 1):622-30. doi: 10.1097/01.gme.0000123641.76105.b5. Menopause. 2004. PMID: 15545790 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters